Recovering scientist helping tell the biotech stories | Surf San Diego, Ski Utah | PR @ little dog communications @litldog
San Diego, CA
Joined May 2008
- Tweets4K
- Following780
- Followers1K
- Likes2K
Starting at 2:45pm PT! #SYNBIOBETA2024
#SynBioBeta2024 Day 2! Join our CTO Phil Paik and @staciakwyman, from @igisci, at 2:45pm in Room 210B.
Or visit us at Booth 107 in @SynBioBeta Exhibition Hall to find out more about our #FES technology for #DNAuncompromised.
112
So exciting to see this come together today! Looking forward to the discussions on #singlecell and #AI in #medicine!
cellarity.com/news/cellarity…
#SCAIM22 @cellaritybio @FlagshipPioneer
For those who have heard me talk about the three "D's" in #biotech #PR, there are also three "D's" in #geneticmedicines: Delivery, Delivery, Delivery.
It's been great to work with the team at GenEdit to support this collaboration announcement with Sarepta.
We're excited to announce our collaboration with @Sarepta to develop new #geneticmedicines for neuromuscular diseases and the progress we have made together in using our #NanoGalaxy platform to target muscle for #geneediting.
Read more: genedit.com/news/sarepta-the…
If you're looking for it, here's the first program to be funded under Biden's $3B Antiviral Program for Pandemics
biocentury.com/article/64165…
@BioCentury @steveusdin1
We announced today the advancement of our highly potent #SARSCoV2 #PLpro inhibitors in discovery of an oral direct-acting #antiviral to treat #COVID19 and the signing of a CRADA with the #NIH
clearcreekbio.com/clear-cree…
#boston #biotech #smallmolecule #infectiousdisease #antivirals
Congrats! 👏👏👏👏
We've closed a $50M financing to take our 3-in-1 #myxoma #immunotherapy into #clinicaltrials.
oncomyx.com/oncomyx-closes-5…
@LumiraVentures @BCapitalGroup, LYZZ Capital, @xerayacapital @CityHillVC @ASU @ASUBiodesign, Skysong Innovations, @AZBio @Biomed_PHX @PHXEconDev @MayorGallego
What's going to get us out of this #pandemic?
An #intranasal #COVID_19 #vaccine.
While there are only a handful in development, we just need one...and this clinical data is very promising.
#COVID19 #intranasalvaccine #client #biotech #BayArea
This Post is from an account that no longer exists. Learn more
1
It's so great to see Artiva grow as a company from just two people to an industry leader -- not just in #nkcelltherapy but also in #CSR. From the beginning, they were focused on "doing more" -- more for cancer patients, and now they are taking that a step further.
#wecandomore
Artiva Biotherapeutics Demonstrates Its Commitment to Corporate Social Responsibility by Joining Pledge 1% Movement
artivabio.com/artiva-biother…
@PledgeOne #Pledge1 #ESG #CSR #corporategiving #biotech #nkcelltherapy #cancer #oncology #immunotherapy #immunooncology #celltherapy
3
Sometimes I am just stopped in my tracks with what my clients are advancing...their dedication, their innovation, what they've done already and what they want to do.
#cantstopwontstop #curecancer
Oncolytic Immunotherapy: Q&A With OncoMyx Therapeutics CEO Steve Potts
seekingalpha.com/instablog/4…
#oncology #cancer #tumors #immunotherapy #phoenix #biotech #oncolyticviruses #virotherapy #ASCO21
1
Almost all of our business comes from referrals or repeat entrepreneurs. This is another company from the cofounder of @Synthorx and RQx.
Fun fact: he's started all his companies, including Synthorx, with $7 million.
#PR #biotech #sandiego
Onchilles Pharma Raises $7 Million Series A to Advance Drug Candidates to Activate Newly Discovered Broad-Acting Anticancer Pathway
onchillespharma.com/2021/06/…
#biotech #sandiego #financing #cancer #neutrophils #anticancerprotein #biologic #cancerresearch #ELANE
1
If you're interested in more on this, check out:
article by @MaxGelman for @endpts
endpts.com/lillys-covid-19-p…
article by @akuchment for @dallasnews
dallasnews.com/news/2021/05/…
article by @TheAlexKnapp for @Forbes
forbes.com/sites/alexknapp/2…
#biotech #innovation #COVID19 #antibodies
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
Preprint data shows LY-CoV1404 binds and neutralizes all currently known circulating SARS-CoV-2 variants of concern: ow.ly/fMBx50EEbh8
1
Thank you @gabygoldbergsci for the chance to tell my story about how I went from a PhD in biomedical sciences from @UCSDBMS @UCSanDiego to a career in #biotech #PR.
#datadealsdollarsdrama #SanDiego #careers
In S1Ep5, @jyingling walks us through her science journey—from being a medical translator for her mother to starting @litldog, her own #publicrelations firm focusing on biotech companies. Listen here: spoti.fi/3qvS8qi or wherever you get your #podcasts! 🧵
Why another COVID-19 vaccine?
Intranasal administration and global access is needed to stop transmission of the virus.
This Post is from an account that no longer exists. Learn more
3
We are very excited to be part of this project to apply our #DNA #enzymaticsynthesis tech to create a mobile medical manufacturing platform to make vaccines and other medical countermeasures - anytime, anywhere.
#COVID19 #synbio #synbio101 #RNA #vaccines #enzymes
@maramosaaa @sandyhamada -- you probably want to be following @Yingerdinger =D. Unless you want #biotech news.
Still remember that time I got an email from UCLA saying I got into film school -- I was pretty confused!
1
2
When you're monitoring service picks up your name twin and it's amazingly great news.
Congrats @Yingerdinger!
deadline.com/2021/02/rom-com…
1
Interesting take for #GenomeUK #BioIT considerations from PetaGene re:
- data security, privacy
- technical barriers to efficient IT, low cost
- computational reproducibility, support existing pipelines
- data integrity, info loss
See their 7-slide deck
petagene.com/petagene-genome…
Genomics has the potential to transform the future of healthcare.
Landmark strategy launched by @MattHancock
Key numbers
5 million genomes sequenced by 2023/24
500,000 WGS through NHS Genomic Medicine Service
500,000 WGS through UK Biobank
gov.uk/government/news/landm…
Now I wonder what was on the tip sheet!
Here's a funny sidelight to the CRISPR story.
When Charpentier Doudna paper came out 2012 in Science, the journal did not highlight it in their tip sheet for journalists as news. It just listed in the obscure "additional reports" category.
No one wrote about it!!!!
1
Another company launch! #AI to deconvolute multicell biology to improve #cancer treatment.
@endpts @MaxGelman
Jim Allison and Pam Sharma back a Canadian AI upstart seeking to solve the tumor stroma puzzle
endpts.com/jim-allison-and-p…
#toronto #boston #biotech #Biotechnologie
We excited to officially announce the launch of Phenomic! Thanks to our investors who see the power in our #AI #DrugDiscovery platform.
CTI Life Sciences Fund, @VenturesAv8, @LuminousVC, @Viva_Innovates, @GarageCapital, @Hike_Ventures, and @CantosVC phenomic.ai/
2
Congrats Kevin!
"We need science and tech to solve some of the big problems in healthcare," Heyries, a cofounder and the company's head of business development, said. "We can't afford to be as inefficient as we've been in the past."
#COVID19 #pandemic #pandemicresponse
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more